enow.com Web Search

  1. Ads

    related to: brca 1 and 2 cancers

Search results

  1. Results from the WOW.Com Content Network
  2. BRCA mutation - Wikipedia

    en.wikipedia.org/wiki/BRCA_mutation

    Inheriting one BRCA1 mutation and one BRCA2 mutation has been reported occasionally; the child's risk for any given type of cancer is the higher risk of the two genes (e.g., the ovarian cancer risk from BRCA1 and the pancreatic cancer risk from BRCA2). Inheriting two BRCA2 mutations produces Fanconi anemia. [9]: 82–85

  3. BRCA1 - Wikipedia

    en.wikipedia.org/wiki/BRCA1

    Only about 3%–8% of all women with breast cancer carry a mutation in BRCA1 or BRCA2. [70] Similarly, BRCA1 mutations are only seen in about 18% of ovarian cancers (13% germline mutations and 5% somatic mutations). [71] Thus, while BRCA1 expression is low in the majority of these cancers, BRCA1 mutation is not a major cause of reduced ...

  4. BRCA2 - Wikipedia

    en.wikipedia.org/wiki/BRCA2

    A patent application for the isolated BRCA1 gene and cancer-cancer promoting mutations, as well as methods to diagnose the likelihood of getting breast cancer, was filed by the University of Utah, National Institute of Environmental Health Sciences (NIEHS) and Myriad Genetics in 1994; [42] over the next year, Myriad, in collaboration with other ...

  5. Hereditary breast–ovarian cancer syndrome - Wikipedia

    en.wikipedia.org/wiki/Hereditary_breast–ovarian...

    People with BRCA1 and BRCA2 mutations are recommended to have a transvaginal ultrasound 1-2 times per year. Screening with CA-125 is also recommended.. Prophylactic salpingo-oophorectomy (removal of the ovaries and fallopian tubes to prevent cancer) is recommended at age 35-40 for people with BRCA1 mutations and at age 40-45 for people with BRCA2 mutations. [6]

  6. High-grade serous carcinoma - Wikipedia

    en.wikipedia.org/wiki/High-grade_serous_carcinoma

    A mutation in BRCA1 or BRCA2 can confer a lifetime ovarian cancer risk of 40-50% and 10-20% respectively, [15] with BRCA2 mutations strongly associated with better clinical outcomes. A specific tumour protein 53 ( TP53 ) expression pattern in the Fallopian tube epithelium – the ‘p53 signature’ - is thought to be a precursor marker of HGSC.

  7. Loss of heterozygosity - Wikipedia

    en.wikipedia.org/wiki/Loss_of_heterozygosity

    The genes BRCA1 and BRCA2 show loss of heterozygosity in samplings of tumors from patients who have germline mutations. [citation needed] BRCA1/2 are genes that produce proteins which regulate the DNA repair pathway by binding to Rad51. [citation needed]

  8. SEE-FIM Protocol - Wikipedia

    en.wikipedia.org/wiki/SEE-FIM_Protocol

    BRCA – Breast cancer associated tumor suppressor genes, including BRCA1 and BRCA2. Inherited (germline) loss of a BRCA gene imposes an increased risk of breast and ovarian cancer. TP53 – A tumor suppressor gene that is mutated in High grade serous carcinoma. RRSO – Risk reduction salpingo-oophorectomy. RRS – Risk reduction salpingectomy.

  9. Triple-negative breast cancer - Wikipedia

    en.wikipedia.org/wiki/Triple-negative_breast_cancer

    [2] Triple-negative breast cancer comprises 15–20% of all breast cancer cases [3] and affects more young women or women with a mutation in the BRCA1 gene than other breast cancers. [4] Triple-negative breast cancers comprise a very heterogeneous group of cancers. TNBC is the most challenging breast cancer type to treat. [5]

  1. Ads

    related to: brca 1 and 2 cancers